Efsubaglutide Alfa
Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery
Shanghai Yinnuo Pharmaceutical Technology Co · Phase 4 · Recruiting · Enrollment 60
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Efsubaglutide Alfa group | n/r | n/r | n/r | n/r |
| control group | n/r | n/r | n/r | n/r |
Not shown
- Efsubaglutide Alfa group: endpoint not reported
- control group: endpoint not reported